search icon
ngenf-img

NervGen Pharma Corp, Common Stock

NGENF

PNK

$2.54

+$0

(0%)

1D
Industry: Biotechnology Sector: Health Care

Analyst Forecast

Price Chart

Key Metrics

Market Cap info-icon
This is a company’s total value as determined by the stock market. It is calculated by multiplying the total number of a company's outstanding shares by the current market price of one share.
$189.91M
P/E Ratio info-icon
This is the ratio of a security’s current share price to its earnings per share. This ratio determines the relative value of a company’s share.
0
Volume info-icon
This is the total number of shares traded during the most recent trading day.
91.79K
Avg Volume info-icon
This is the average number of shares traded during the most recent 30 days.
0
Dividend Yield info-icon
This ratio shows how much income you earn in dividend payouts per year for every dollar invested in the stock (or the stock’s annual dividend payment expressed as a percentage of its current price).
0.00%
Beta info-icon
This measures the expected move in a stock’s price relative to movements in the overall market. The market, such as the S&P 500 Index, has a beta of 1.0. If a stock has a Beta greater (or lower) than 1.0, it suggests that the stock is more (or less) volatile than the broader market.
0.64
52-week Range info-icon
This shows the range of the stock’s price between the 52-week high (the highest price of the stock for the past 52 weeks) and the 52-week low (the lowest price of the stock for the past 52 weeks).
$1.46 L
$5.1 H
$2.54

About NervGen Pharma Corp, Common Stock

NervGen Pharma Corp., a biotechnology company, engages in the discovery, development, and commercialization of pharmaceutical treatments to promote nervous system repair in settings of neurotrauma and neurologic disease. The company's lead product candidate is NVG-291 that is in Phase 1b/2a clinical trial for the treatment of spinal cord injuries (SCI), stroke, multiple sclerosis, and Alzheimer's disease; and NVG-300, which is in a preclinical model of ischemic stroke and confirmatory SCI study. NervGen Pharma Corp. has a licensing agreement with Case Western Reserve University to develop and commercialize a patented technology with therapeutic potential for spinal cord injury and other conditions associated with nerve damage. The company was incorporated in 2017 and is based in Vancouver, Canada. more

Industry: BiotechnologySector: Health Care

Returns

Time FrameNGENFSectorS&P500
1-Week Return24.45%-0.41%0.44%
1-Month Return-1.26%0.67%0.9%
3-Month Return-38.11%3.06%8.72%
6-Month Return32.16%-7.86%8.04%
1-Year Return26.24%-12.34%14.61%
3-Year Return66.94%7%58.57%
5-Year Return87.81%27.38%84.92%
10-Year Return95.09%92.29%231.18%

Financials

Dec '20Dec '21Dec '22Dec '23Dec '245YR TREND
Total Revenue-----[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Cost of Revenue-----[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Gross Profit-----[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Gross Margin-----[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Operating Expenses11.20M11.38M23.03M17.78M24.93M[{"date":"2020-12-31","value":44.91,"profit":true},{"date":"2021-12-31","value":45.63,"profit":true},{"date":"2022-12-31","value":92.35,"profit":true},{"date":"2023-12-31","value":71.3,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]
Operating Income(11.20M)(11.38M)(23.03M)(17.78M)(24.93M)[{"date":"2020-12-31","value":-1119588400,"profit":false},{"date":"2021-12-31","value":-1137732700,"profit":false},{"date":"2022-12-31","value":-2302503300,"profit":false},{"date":"2023-12-31","value":-1777671000,"profit":false},{"date":"2024-12-31","value":-2493199500,"profit":false}]
Total Non-Operating Income/Expense9.74K(1.35M)2.30M(4.61M)926.10K[{"date":"2020-12-31","value":0.42,"profit":true},{"date":"2021-12-31","value":-58.59,"profit":false},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":-200,"profit":false},{"date":"2024-12-31","value":40.22,"profit":true}]
Pre-Tax Income(11.19M)(12.73M)(20.72M)(22.38M)(24.01M)[{"date":"2020-12-31","value":-1118614100,"profit":false},{"date":"2021-12-31","value":-1272657800,"profit":false},{"date":"2022-12-31","value":-2072228300,"profit":false},{"date":"2023-12-31","value":-2238212000,"profit":false},{"date":"2024-12-31","value":-2400589500,"profit":false}]
Income Taxes-----[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Income After Taxes-----[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Income From Continuous Operations(11.19M)(12.73M)(20.72M)(22.38M)(24.01M)[{"date":"2020-12-31","value":-1118614100,"profit":false},{"date":"2021-12-31","value":-1272657800,"profit":false},{"date":"2022-12-31","value":-2072228300,"profit":false},{"date":"2023-12-31","value":-2238212000,"profit":false},{"date":"2024-12-31","value":-2400589500,"profit":false}]
Income From Discontinued Operations-----[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Net Income(11.19M)(12.73M)(20.72M)(22.38M)(24.01M)[{"date":"2020-12-31","value":-1118614100,"profit":false},{"date":"2021-12-31","value":-1272657800,"profit":false},{"date":"2022-12-31","value":-2072228300,"profit":false},{"date":"2023-12-31","value":-2238212000,"profit":false},{"date":"2024-12-31","value":-2400589500,"profit":false}]
EPS (Diluted)(0.26)(0.31)(0.39)(0.28)(0.25)[{"date":"2020-12-31","value":-26.4,"profit":false},{"date":"2021-12-31","value":-30.94,"profit":false},{"date":"2022-12-31","value":-39.44,"profit":false},{"date":"2023-12-31","value":-27.9,"profit":false},{"date":"2024-12-31","value":-25.29,"profit":false}]

Ratios

Liquidity

These ratios help you determine the liquidity of the company. Higher is better.

NGENF
Current Ratio 1.06

Asset Efficiency

These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.

NGENF
ROA (LTM) -68.24%
ROE (LTM) -253.35%

Liabilities

These ratios help you understand the company's liabilities, gauging the riskiness of the investment.

NGENF
Debt Ratio Lower is generally better. Negative is bad. 0.91
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. 0.09

Valuation

These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.

NGENF
Trailing PE NM
Forward PE NM
P/S (TTM) 0.00
P/B 189.17
Price/FCF NM
EV/R 0.00
EV/Ebitda NM

FAQs

What is NervGen Pharma Corp share price today?

NervGen Pharma Corp (NGENF) share price today is $2.54

Can Indians buy NervGen Pharma Corp shares?

Yes, Indians can buy shares of NervGen Pharma Corp (NGENF) on Vested. To buy NervGen Pharma Corp from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in NGENF stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.

Can Fractional shares of NervGen Pharma Corp be purchased?

Yes, you can purchase fractional shares of NervGen Pharma Corp (NGENF) via the Vested app. You can start investing in NervGen Pharma Corp (NGENF) with a minimum investment of $1.

How to invest in NervGen Pharma Corp shares from India?

You can invest in shares of NervGen Pharma Corp (NGENF) via Vested in three simple steps:

  • Click on Sign Up or Invest in NGENF stock at the top of this page
  • Breeze through our fully digital and secure KYC process and open your US Brokerage account in a few minutes
  • Transfer USD funds to your US Brokerage account and start investing in NervGen Pharma Corp shares
What is NervGen Pharma Corp 52-week high and low stock price?

The 52-week high price of NervGen Pharma Corp (NGENF) is $5.1. The 52-week low price of NervGen Pharma Corp (NGENF) is $1.46.

What is NervGen Pharma Corp price-to-book (P/B) ratio?

The price-to-book (P/B) ratio of NervGen Pharma Corp (NGENF) is 189.17

What is the Market Cap of NervGen Pharma Corp?

The market capitalization of NervGen Pharma Corp (NGENF) is $189.91M

What is NervGen Pharma Corp’s stock symbol?

The stock symbol (or ticker) of NervGen Pharma Corp is NGENF

Signup to access all features and start your US investing journey!

  • Open your account in minutes
  • Take your portfolio global, starting at just $1
Get started

Add ticker to compare

Scroll to Top